Incident heart failure with preserved ejection fraction
There are 6 papers on incident heart failure with preserved ejection fraction in aging research: 5 observational studies in people, 1 review. The newest story, Nov 7, 2026: “Heart-tracing model predicted two types of heart failure”.
BMP10 was not clearly linked with incident heart failure with preserved ejection fraction in humans (Secondary analysis in participants initially free of heart failure) (HR 1.38, 95% CI 0.60–3.16; no significant association).
“but not with incident HFpEF (HR:1.38; 95%CI: 0.60–3.16).”
HumansSecondary analysis in participants initially free of heart failureMedian follow-up of 19.1 years51.7% womensn = 6,028
Lipoprotein is associated with incident heart failure with preserved ejection fraction in humans (Without prevalent heart failure; adjusted for cardiovascular risk factors) (Per-SD HR 1.06, 95% CI 1.01-1.11).
“After multivariable adjustment, the association was attenuated but persisted (perSD HR 1.06, 95% CI 1.01-1.11, p=0.010)”
Change in left atrioventricular coupling index predicts incident heart failure with preserved ejection fraction in humans (Adults free of clinical cardiovascular disease) (HR 1.41, 95% CI 1.21–1.61 per 1-SD increase).
“Each 1-standard deviation (SD) increase in ∆LACI independently predicted HFpEF (hazard ratio (HR) 1.41, 95% confidence interval (CI) 1.21-1.61, p<0.001)”
Artificial intelligence beat a clinical risk-factor model for predicting one subtype, scoring 0.86 versus 0.78, but scored modestly lower for the other.Artificial intelligence beat a clinical risk-factor model for predicting one subtype, scoring 0.86 versus 0.78, but scored modestly lower for the other.
Who was studiedPeople without prior heart failure, 10 years, against a clinical risk-factor model
What changedPrediction scores were higher for reduced-ejection-fraction heart failure (0.86 versus 0.78) but lower for preserved-ejection-fraction heart failure (0.78 versus 0.81)
The catchThe evaluation measured prediction, not whether using predictions prevented heart failure
In Massachusetts General Hospital’s test group, 10-year prediction scores were 0.87 for heart failure with reduced ejection fraction and 0.79 for preserved ejection…In Massachusetts General Hospital’s test group, 10-year prediction scores were 0.87 for heart failure with reduced ejection fraction and 0.79 for preserved ejection fraction.
A rising heart volume index carried a hazard ratio of 1.41 for preserved-ejection heart failure against 1.18 for heart failure with reduced ejection.A rising heart volume index carried a hazard ratio of 1.41 for preserved-ejection heart failure against 1.18 for heart failure with reduced ejection.
An observational analysis followed 4,177 Black adults for a median 12 years; the association held in people with and without anemia.An observational analysis followed 4,177 Black adults for a median 12 years; the association held in people with and without anemia.
Glucagon-like peptide-1 receptor agonists were linked to a lower combined hazard of death, heart attack or stroke than comparator drugs, with a hazard ratio of 0.799.Glucagon-like peptide-1 receptor agonists were linked to a lower combined hazard of death, heart attack or stroke than comparator drugs, with a hazard ratio of 0.799.
Who was studiedAdults with obesity and elevated CRP, up to 3,650 days
What changedCombined death, heart attack, or stroke risk was lower with glucagon-like peptide-1 receptor agonists than comparator drugs (hazard ratio 0.799)
The catchWeight and inflammation changes during follow-up were not measured